Pregled bibliografske jedinice broj: 313890
Generation of ammodytoxin-anti-cathepsin B immuno-conjugate as a model for delivery of secretory phospholipase A2 into cancer cells
Generation of ammodytoxin-anti-cathepsin B immuno-conjugate as a model for delivery of secretory phospholipase A2 into cancer cells // Toxicon, 51 (2008), 5; 754-764 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 313890 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Generation of ammodytoxin-anti-cathepsin B immuno-conjugate as a model for delivery of secretory phospholipase A2 into cancer cells
Autori
Premzl, Ales ; Kovačić, Lidija ; Halassy, Beata ; Križaj, Igor
Izvornik
Toxicon (0041-0101) 51
(2008), 5;
754-764
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
snake venom; Vipera ammodytes ammodytes; secreted phospholipase A2; ammodytoxin; immuno-conjugate; cancer
Sažetak
Ammodytoxin (AtxC) is a toxic secreted phospholipase A2 (sPLA2) from the venom of Vipera ammodytes snake. To evaluate its potential to kill cancer cells, the toxin was cross-linked to the monoclonal antibody against cathepsin B which endocytose upon binding to cathepsin B, an antigen overexpressed on the plasma membrane of cancer cells. Sulfo-SBED derivative of AtxC, possessing the same biological activity as the wt toxin, was photo-reacted with antibodies to form a covalent immuno-conjugate. In the cytosol-like conditions AtxC was gradually released from the conjugate due to reduction of the disulfide bond in the spacer arm of the cross-linker. The pshospholipase activity of the preparation reached maximum in 10 minutes and then decreased gradually. As demonstrated by fluorescence microcopy, the immuno-conjugate targeted Caco-2 colon adenocarcinoma cells but was just very slowly internalized, the likely reason of only slight citotoxicity observed in MTT test. Despite the lack of clear cytotoxic effect of AtxC-antibody conjugate od Caco-2 cells we demonstrated in this work a new methodology for targeted delivery of the (toxic) sPLA2 into cells, promising in research or therapy.
Izvorni jezik
Engleski
Znanstvena područja
Biologija, Temeljne medicinske znanosti, Drvna tehnologija
POVEZANOST RADA
Projekti:
021-0212432-2033 - Imunogeničnost komponenti kompleksnih antigena (Halassy, Beata, MZOS ) ( CroRIS)
Ustanove:
Imunološki zavod d.d.
Profili:
Beata Halassy
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE